Drug Database
Back to search

Netherlands· NL-d32bc483fc95

Bleu Patente V, oplossing voor injectie 25 mg/ml

A patentblau v product containing patentblauw v (e 131), registered in Netherlands by Guerbet. The same ATC class is registered in 4 of our 19 countries.

ATC V04CX09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBleu Patente V, oplossing voor inject…ATCV04CX09REGISTER NO.NL-d32bc483fc95PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about patentblauw v (e 131)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Patentblau v is registered in 4 of 19 countries.

Countries holding a registration under ATC V04CX09 (patentblau v), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search patentblau v products by name

Patentblau v · ATC V04CX09

4 / 19 countries

  • Belgiumprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PATENTBLAUW V (E 131)
Manufacturer
Guerbet
Country
Netherlands (NL)
ATC code
V04CX09
ATC class
Patentblau V
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    08193

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V04CX09

Patentblau v, as other registers publish it.

All patentblau v products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/51af4f2f-b3ac-452d-90e2-2ee79c4ce04e
GET /v1/drugs/51af4f2f-b3ac-452d-90e2-2ee79c4ce04e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik, Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08193_smpc.pdf",
  "strength": null,
  "atc_label": "Patent blue",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg08193",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "NATRIUMCHLORIDE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "PATENTBLAUW V (E 131)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h08193.pdf",
  "authorised_at": "1976/05/10",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "08193",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about patentblau v.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console